• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

Ethereum Price: Concerns Among Long-term Holders

user avatar

by Giorgi Kostiuk

10 months ago


Ethereum's price has breached a long-term support level, raising concerns among long-term holders. Current NUPL figures indicate potential market shifts.

Ethereum Price Breaking Long-term Support Level

The recent decline in Ethereum's price dented investor confidence as historic support points failed to hold. However, ETH remains supported around $1,950. The $2K-$2.1K range is crucial for potential large timeframe reversals, and reclaiming this could move it up to $2,400-$2,500, easing short-term bearish concerns.

Historical ETH's Q1 Performances

Ethereum is set to finish its worst Q1 ever, reflecting serious investor fears. ETH traditionally had strong Q1 performances, but 2024 has seen difficulties returning to key levels. The current three-month rolling performance shows ongoing weakness and increasing selling pressure.

Current Fear Level Analysis

The current NUPL level is at 0.38, indicating a shift from hope to fear. If the fear escalates, Ethereum could continue falling below current support levels. A return to a NUPL of 0.45 may imply a retest of levels above $2,500. Market indecision remains: further falls confirm capitulation, but staying here could lead to a new rally.

Ethereum's situation remains uncertain as its price hovers around key support levels. Observations in the coming weeks will reveal if the bearish trend persists or if recovery is possible.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Converge Bio's AI Platform Aims to Transform Drug Development

chest

Converge Bio is leveraging its newly acquired $25 million funding to enhance its AI platform, which focuses on drastically reducing the time and costs associated with drug development.

user avatarKenji Takahashi

Converge Bio Secures $25 Million Series A Funding to Transform Drug Discovery

chest

Converge Bio, a startup based in Boston and Tel Aviv, has raised $25 million in Series A funding to enhance AI-driven drug discovery.

user avatarMaria Fernandez

Buterin Continues Charity Donations from Token Sales

chest

Vitalik Buterin continues his practice of selling unsolicited tokens and donating the proceeds to charity, emphasizing ethical considerations in cryptocurrency promotions.

user avatarRajesh Kumar

Vitalik Buterin Sells Unsolicited Tokens for 94 ETH

chest

Ethereum cofounder Vitalik Buterin has sold unsolicited tokens from his wallet, converting them into 94 ETH.

user avatarGustavo Mendoza

Grayscale Segments Crypto Market into Five Vertical Categories

chest

Grayscale has categorized its altcoin candidates into five verticals, reflecting a structured approach to the crypto market.

user avatarMiguel Rodriguez

Decline in FLOW Price Amid Controversial Asset Recovery

chest

The price of FLOW has seen a significant decline following the Flow project's controversial asset recovery actions.

user avatarLuis Flores

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.